(Q36465308)

14 August 2017

Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma (English)

1 reference

14 August 2017

1 reference

Jansen HM

1

1 reference

14 August 2017

The TH

series ordinal

2

1 reference

14 August 2017

Orie NG

series ordinal

3

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 October 1980

1 reference

14 August 2017

1 reference

14 August 2017

35

1 reference

14 August 2017

10

1 reference

14 August 2017

781-787

1 reference

BCG and cancer (first of two parts).

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=471380

Immunology of bronchial carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=471380

Immunotherapy with BCG administered by scarification. Standardization of reactions and management of side effects

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=471380

Clinical trials of immunotherapy. Present status

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=471380

Adjuvant immunotherapy with BCG in squamous-cell bronchial carcinoma. Immune-reactivity in relation to immunostimulation (preliminary results in a controlled trial)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=471380

Disseminated bcg disease associated with immunotherapy by scarification in acute leukemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=471380

Cell-mediated immune response in patients with bronchial carcinoma. Relation between clinical parameters and various immunological tests for immune status investigation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=471380

Clinical research on the treatment of locally advanced lung cancer.Final report of VALG protocol 13 limited

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=471380

Treatment of bronchogenic carcinoma. II. Small cell

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=471380

The immune response at the tumor site in lung carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=471380

Regional immunotherapy of lung cancer with intrapleural B.C.G

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=471380

The results of a combined attack on bronchial carcinoma by radiotherapy and surgery

30 September 2017

1 reference

12 December 2020

A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES

1 reference

12 December 2020

Intrapleural B.C.G. immunostimulation in lung cancer

1 reference

12 December 2020

Hazards and Complications of BCG Immunotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1136/THX.35.10.781

1 reference

14 August 2017

1 reference

14 August 2017

1 reference